Alcon stock gets fresh backing from Pershing Square ahead of Q3
Published on 11/05/2026 at 17:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNew investor support ahead
- Pershing Square describes Alcon as a predictable, high-quality compounder with strong margin expansion.
- The investor letter points to raised full-year guidance and a potential earnings-growth runway over the next three to five years.
- Alcon's third-quarter results are scheduled for November 10.
Pershing Square has added a fresh positive investment case for Alcon ahead of the company's third-quarter results. In its Q3 2026 investor letter, the investment firm cited strong second-quarter results, robust margin expansion and earnings upside against modest expectations.
The letter, reported by Yahoo Finance, said Alcon had raised full-year guidance to target 12% to 15% constant-currency earnings-per-share growth. Pershing Square also cited foreign-exchange support for earnings and described the stock as trading at 17 times earnings, its lowest-ever multiple according to the investor letter.
What has changed since our last report
The new investor commentary adds a valuation and margin perspective to the recent Alcon coverage. Pershing Square expects the eye-care company to generate mid-teens earnings growth over the next three to five years and argues that the multiple could expand if execution confirms the company's underlying quality.
Alcon develops surgical equipment, vision-care products, contact lenses and related technologies. The next scheduled test is the third-quarter report on November 10, when investors will assess demand across the Surgical and Vision Care businesses and the conversion of product initiatives into sales and earnings.
Alcon stock traded at 68.45 euros on Lang & Schwarz at 17:44 CET on Thursday, November 5, 2026, up 9.26% from the 62.65 euros quoted in our October 27 report. The move is a comparison with that earlier report and is separate from the daily Xetra comparison.
For the real-time quote of Alcon stock, investors can follow the latest Lang & Schwarz trading indication.
The Swiss market environment can be followed through the Swiss Market Index.
More news and analyses on Alcon stock
Alcon Inc. key facts
- Company: Alcon Inc.
- ISIN: CH0432492467
- Ticker: ALC
- Business: Eye-care medical technology
- Lang & Schwarz quote: 68.45 euros on November 5, 2026 at 17:44 CET
- Change since October 27 report: 9.26%
